BioXcel Therapeutics, Inc. — SCHEDULE 13G/A Filings
3 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by BioXcel Therapeutics, Inc. (BTAI), sorted by most recent first. Each row links to the full filing on EdgarLookup. BioXcel Therapeutics, Inc. has filed 3 SCHEDULE 13G/A documents with the SEC since 2017. To view all SEC filings by BioXcel Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
144/A
3
3/A
4
4/A
424B4
424B5
424B7
5
8-A12B
8-K
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEL AM
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POSASR
PRE 14A
RW
RW WD
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001104659-26-012072 | Feb 9, 2026 | — |
| SCHEDULE 13G/A | — | 0001140361-25-019286 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-002273 | May 15, 2025 | — |